Rothenberg Mace - Insider Non-Derivative Transactions at Tango Therapeutics, Inc. (TNGX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 5, 2024, Rothenberg Mace's relationship to Tango Therapeutics, Inc. (TNGX) is Director, and currently has 11,250 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TNGX insiders.
Data Source: SEC.
Rothenberg Mace - Insider Non-Derivative Transactions of TNGX Common Stock
Rothenberg Mace - Insider Non-Derivative Transactions at TNGX
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 6, 2024 | Acquisition -- (Common Stock) | 6,250 | 0 | 11,250 |
| Jun 7, 2023 | Acquisition -- (Common Stock) | 5,000 | 0 | 5,000 |
Items per page:
1 – 2 of 2